No Data
No Data
Bullish market stimulation boosts Hong Kong healthcare stocks, causing Lai Kai Pharmaceuticals to surge over 18%.
①What bullish news about pharmaceutical stocks has recently been announced in the market? ②How do institutions view the subsequent performance of pharmaceutical stocks?
Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation
①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.
On November 18, essex bio-tech (01061.HK) spent 0.0482 million Hong Kong dollars to repurchase 0.019 million shares.
Gelonghui November 18丨essex bio-tech (01061.HK) announced that on November 18, 2024, it spent 0.0482 million Hong Kong dollars to repurchase 0.019 million shares, with a repurchase price of 2.53-2.59 Hong Kong dollars per share.
The new policy of prepayment of medical insurance fund has been released, and the pharmaceutical sector has ushered in a sharp rise. Experts believe it may be a way for medical institutions to release funding pressure.
On the 11th, the "Notice on Prepayment of Medical Insurance Fund" was issued, requiring the unified and improved basic medical insurance fund prepayment system at the national level. Experts believe that the prepayment system can effectively alleviate the problem of pharmaceutical industry debt, accelerate the turnover of funds for pharmaceutical companies. The medical sector showed a significant upward trend today, with listed companies attributing the rise to investor sentiment.
Multiple bullish factors boost pharmaceutical Hong Kong stocks. Institutions say they still face this risk in the short term.
①What are the policy measures to support the field of innovative drugs? ②What unfavorable effects on domestic pharmaceutical stocks might Trump's election bring about?
essex bio-tech (01061.HK) spent 0.0996 million Hong Kong dollars to buy back 0.04 million shares on November 6th.
GLH Nov. 6 | Essex Bio-Tech (01061.HK) announced that on Nov. 6, 2024, it spent 0.0996 million Hong Kong dollars to repurchase 0.04 million shares at a repurchase price of 2.48-2.5 Hong Kong dollars per share.
No Data
No Data
Syuee : Penny stocks are the realm of dreams and nightmares for speculators.
HopeAlways : Penny stocks are speculative in nature, and tend to more volatile; more suited for day trading and those who can stomach higher risks.
HuatEver : I started my trading journey with Penny Storks, well guided by a sharp witted mentor. This “1st pot of gold” has got me “hooked” on to Moomoo’s trading platform.
HuatLady OP HuatEver : A very auspicious beginning to add to your trading portfolio.
HuatLady OP HopeAlways : I reckon you have blacklisted penny stocks trading as red flags.
View more comments...